ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines classify allergic rhinitis severity and persistence. A patient with nasal symptoms for 4 days per week, lasting more than 4 consecutive weeks, with significant impact on work/school activities, is classified as:

• A Intermittent, mild
• B Persistent, mild
• C Persistent, moderate-severe ✓
• D Intermittent, moderate-severe

Explanation

The ARIA classification uses two axes: (1) Duration — intermittent (<4 days/week OR <4 consecutive weeks) versus persistent (≥4 days/week AND ≥4 consecutive weeks); (2) Severity — mild (normal sleep, no impairment of daily activities/work/school, no troublesome symptoms) versus moderate-severe (≥1 of: sleep disturbance, impairment of daily/work/school activities, troublesome symptoms present). This patient has symptoms 4 days/week for >4 weeks (persistent) with work impact (moderate-severe), making the classification Persistent, Moderate-Severe (PMoS). This classification guides step-up therapy: PMoS requires second-generation antihistamines + intranasal steroids as first-line.

Reference: Dhingra Diseases of Ear, Nose and Throat, 7th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.